Tasimelteon, the first new drug for the treatment of non-24-hour sleep-wake disorder in totally blind individualsDU Shan, SHU Yong-quan1351-1353,1389
Effects on trends of global pharmaceutical R&D by "blockbuster drugs"SU Yue, GUAN Zhen-he, GENG Xiang-nan, PU Run, AO Yi1354-1358,1397
Evaluation and requirement for clinical trials of innovative vaccinesAI Xing, YANG Zhi-min, YANG Huan1367-1370,1417
Network pharmacological studies of Huoxiang Zhengqi pill in treating functional dyspepsiaSHI Qi-lin, MA Xiao-hui, YAN Lu-lu, XU Xiao-jie, SUN He1371-1377,1422
General requirements for incurred sample reanalysis in clinical pharmacokinetic studies and the interpretationLI Min, SHI Ai-xin, LI Ke-xin, HU Xin1378-1381
Progress in research on structure-function of influenza virus polymerase as an antiviral targetLI Bei-bei, ZHOU Lin-ting, WU Jin-yan1390-1397
Evaluation methods of colon specific drug delivery system in vitro and in vivoWANG Shao-jing, ZHANG Xue-shun1398-1401
Progress in research on small molecular inhibitors of Hedgehog signal pathway毛耀南, 胡兵, 蔡进, 陈峻青, 宗玺, 王鹏, 张蕊, 吉民1402-1409